 Diagnostic utility flumazenil coma suspected poisoning double blind study OBJECTIVE diagnostic value safety benzodiazepine antagonist flumazenil patients coma unclear origin suspected poisoning DESIGN Double blind placebo study SETTING Intensive care unit major teaching hospital PATIENTS Unconscious adults suspected drug overdosage months total cases Exclusion criteria pregnancy epilepsy obvious drugs information relatives others benzodiazepines coma score scale Patients flumazenil men women placebo men women INTERVENTIONS Intravenous injection flumazenil ml mg/ml placebo ml vehicle double blind minutes MAIN OUTCOME MEASURES Serum urine concentrations benzodiazepines antidepressants several agents blood gas tensions evaluation admission minutes injection means coma scale score urgent diagnostic therapeutic interventions history clinical examination interview injection information adverse reactions RESULTS Benzodiazepines serum patients flumazenil group placebo average coma scale score injection flumazenil group placebo group flumazenil group several interventions unnecessary injection gastric lavage urinary catheterisation patients intubation artificial ventilation tomography brain patients blood culture lumbar puncture patient electroencephalography placebo group indications procedures patient injection confidence interval difference reduction frequency indications gastric lavage injection groups intubation urinary catheterisation flumazenil group patients valuable information drug ingestion minutes injection placebo group Nine adverse reactions flumazenil group mild severe safety antagonist acceptable patients flumazenil group multiple drug benzodiazepine epileptic seizures arrhythmias CONCLUSION Flumazenil valuable safe differential diagnostic tool unclear cases multiple drug poisoning